ConductScience.org, home

Trial · NCT03615040

Results by group216

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Number of Moderate to Severe Exacerbation (Defined as Requiring Treatment With Systemic Corticosteroids and/or Antibiotics in the Community or Hospital or Hospitalisation).Anti-ST22.21Standard Deviation 2.04Exacerbations
Number of Moderate to Severe Exacerbation (Defined as Requiring Treatment With Systemic Corticosteroids and/or Antibiotics in the Community or Hospital or Hospitalisation).Placebo2.67Standard Deviation 2.14Exacerbations
Adverse Event Rate in the 48 Weeks of the Trial From First DoseAnti-ST234Participants
Adverse Event Rate in the 48 Weeks of the Trial From First DosePlacebo28Participants
Serious Adverse Event Rate in the 48 Weeks of the Trial From First DoseAnti-ST212Participants
Serious Adverse Event Rate in the 48 Weeks of the Trial From First DosePlacebo16Participants
St George's Respiratory Questionnaire for COPD Patients (SGRQ-C) Total ScoreAnti-ST2Baseline60.1Standard Deviation 13.7score on a scale
St George's Respiratory Questionnaire for COPD Patients (SGRQ-C) Total ScorePlaceboBaseline58.4Standard Deviation 17.6score on a scale
St George's Respiratory Questionnaire for COPD Patients (SGRQ-C) Total ScoreAnti-ST2Week 456.7Standard Deviation 13.5score on a scale
St George's Respiratory Questionnaire for COPD Patients (SGRQ-C) Total ScorePlaceboWeek 458.9Standard Deviation 16.5score on a scale
St George's Respiratory Questionnaire for COPD Patients (SGRQ-C) Total ScoreAnti-ST2Week 1256.9Standard Deviation 15.2score on a scale
St George's Respiratory Questionnaire for COPD Patients (SGRQ-C) Total ScorePlaceboWeek 1259.9Standard Deviation 18.2score on a scale
St George's Respiratory Questionnaire for COPD Patients (SGRQ-C) Total ScoreAnti-ST2Week 2456.6Standard Deviation 15.3score on a scale
St George's Respiratory Questionnaire for COPD Patients (SGRQ-C) Total ScorePlaceboWeek 2459.6Standard Deviation 17.9score on a scale
St George's Respiratory Questionnaire for COPD Patients (SGRQ-C) Total ScoreAnti-ST2Week 3659.5Standard Deviation 14.6score on a scale
St George's Respiratory Questionnaire for COPD Patients (SGRQ-C) Total ScorePlaceboWeek 3659.5Standard Deviation 17.0score on a scale
St George's Respiratory Questionnaire for COPD Patients (SGRQ-C) Total ScoreAnti-ST2Week 4857.7Standard Deviation 15.7score on a scale
St George's Respiratory Questionnaire for COPD Patients (SGRQ-C) Total ScorePlaceboWeek 4863.3Standard Deviation 17.2score on a scale
COPD Assessment Test (CAT) (Questionnaire)Anti-ST2Week 022.1Standard Deviation 6.6score on a scale
COPD Assessment Test (CAT) (Questionnaire)PlaceboWeek 022.6Standard Deviation 5.7score on a scale

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03615040/results